(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.06%) $0.927
(0.19%) $10.86
(0.07%) $0.793
(-0.29%) $92.31
Live Chart Being Loaded With Signals
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...
Stats | |
---|---|
Today's Volume | 14.36M |
Average Volume | 10.07M |
Market Cap | 142.87B |
EPS | HKD0.940 ( 2023-10-31 ) |
Last Dividend | HKD0.989 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.54 |
ATR14 | HKD0.0530 (0.14%) |
Volume Correlation
WuXi AppTec Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
WuXi AppTec Co., Ltd. Correlation - Currency/Commodity
WuXi AppTec Co., Ltd. Financials
Annual | 2023 |
Revenue: | HKD40.34B |
Gross Profit: | HKD16.61B (41.18 %) |
EPS: | HKD0 |
Q4 | 2023 |
Revenue: | HKD10.80B |
Gross Profit: | HKD4.41B (40.85 %) |
EPS: | HKD0 |
Q3 | 2023 |
Revenue: | HKD10.67B |
Gross Profit: | HKD4.55B (42.68 %) |
EPS: | HKD0.940 |
Q2 | 2023 |
Revenue: | HKD9.91B |
Gross Profit: | HKD4.07B (41.08 %) |
EPS: | HKD1.070 |
Financial Reports:
No articles found.
WuXi AppTec Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.989 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.281 | 2019-06-17 |
Last Dividend | HKD0.989 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD2.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.38 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3833.HK | Ex Dividend Junior | 2023-06-02 | Sporadic | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0778.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
2317.HK | Ex Dividend Junior | 2023-09-14 | Annually | 0 | 0.00% | |
1299.HK | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
0371.HK | Ex Dividend Junior | 2023-06-12 | Semi-Annually | 0 | 0.00% | |
6078.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
1857.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
0883.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0034.HK | Ex Dividend Knight | 2023-12-15 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.238 | 1.500 | 5.24 | 7.86 | [0 - 0.5] |
returnOnAssetsTTM | 0.130 | 1.200 | 5.65 | 6.78 | [0 - 0.3] |
returnOnEquityTTM | 0.187 | 1.500 | 9.04 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.287 | -1.000 | 7.13 | -7.13 | [0 - 1] |
currentRatioTTM | 2.06 | 0.800 | 4.69 | 3.75 | [1 - 3] |
quickRatioTTM | 1.610 | 0.800 | 5.24 | 4.19 | [0.8 - 2.5] |
cashRatioTTM | 0.933 | 1.500 | 5.93 | 8.89 | [0.2 - 2] |
debtRatioTTM | 0.0780 | -1.500 | 8.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 61.33 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.27 | 2.00 | 8.58 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.39 | 2.00 | 8.81 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.104 | -1.500 | 9.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.47 | 6.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.294 | 1.000 | 6.11 | 6.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.18 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.548 | 0.800 | 9.68 | 7.75 | [0.5 - 2] |
Total Score | 12.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.30 | 1.000 | 9.06 | 0 | [1 - 100] |
returnOnEquityTTM | 0.187 | 2.50 | 9.38 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.39 | 2.00 | 9.20 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.93 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.27 | 2.00 | 8.58 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.287 | 1.500 | 7.13 | -7.13 | [0 - 1] |
pegRatioTTM | 0.521 | 1.500 | 9.86 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.311 | 1.000 | 4.74 | 0 | [0.1 - 0.5] |
Total Score | 7.38 |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators